FDA Adverse Event Malfunction Summary report: N

ALINITY I TOXO IGG REAGENT KIT

MDR report key: 20803110 · Received November 27, 2024

Report

Report Number
3002809144-2024-00338
Event Type
Malfunction
Date Received
November 27, 2024
Date of Event
November 11, 2024
Report Date
December 16, 2024
Manufacturer
ABBOTT GMBH
Product Code
LGD
PMA / PMN Number
K210596
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE COMPLAINT INVESTIGATION INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TICKET TRENDING REVIEW, LABELING REVIEW, DEVICE HISTORY RECORD REVIEW, AND FIELD DATA REVIEW. RETURN TESTING WAS NOT COMPLETED AS RETURNS WERE NOT AVAILABLE. DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE WITHOUT INDICATION FOR ANY ADDITIONAL ISSUE. THE TICKET SEARCH BY LOT INDICATES THAT THE COMPLAINT LOT PERFORMS AS EXPECTED FOR THIS PRODUCT. TICKET TRENDING REVIEW DID NOT IDENTIFY ANY TRENDS REGARDING COMMONALITIES FOR COMPLAINT LOT. DEVICE HISTORY REVIEW DID NOT IDENTIFY ANY NON-CONFORMANCES OR DEVIATIONS WITH THE COMPLAINT LOT. THE OVERALL PERFORMANCE OF THE ALINITY I TOXO IGG REAGENTS IN THE FIELD WAS REVIEWED USING DATA GATHERED FROM CUSTOMERS WORLDWIDE. THE PATIENT MEDIAN VALUES OBTAINED WITH THE COMPLAINT LOT 66438BE00 IS WITHIN ESTABLISHED LIMITS AND THUS COMPARABLE TO THE HISTORICAL LOT PERFORMANCE, WHICH CONFIRMS NO SYSTEMIC ISSUE FOR THE LOT. LABELING WAS REVIEWED AND SUFFICIENTLY ADDRESSES THE CUSTOMER¿S ISSUE. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ALINITY I TOXO IGG REAGENT LOT 66438BE00 WAS IDENTIFIED.

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 07P45-22 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 7P45-40 / 45, WITH 510K/PMA/BLA NUMBER K210596. A1 PATIENT IDENTIFIER: COMPLETE LIST OF SAMPLE ID'S ARE (B)(6). AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSE ELEVATED ALINITY I TOXO IGG AND PROVIDED THE FOLLOWING DATA: CUSTOMER REFERENCE RANGE: POSITIVITY CUTOFF IS 1.2 IU/ML. SAMPLE ID (B)(6), INITIAL RESULT WAS 3.639 AND REPEAT RESULTS WERE 0.064 & 0.643. SAMPLE ID (B)(6), INITIAL RESULT WAS 10.516 AND REPEAT RESULTS WERE 0.062, 0.066 & 0.084. SAMPLE ID (B)(6), INITIAL RESULT WAS 2.053 AND REPEAT RESULTS WERE 0.079 & 0.127. PER THE CUSTOMER THE DISCREPANT RESULTS WERE NOT REPORTED OUT TO THE PATIENT¿S MEDICAL PROVIDER. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.

Description of Event or Problem · 0

THE CUSTOMER REPORTED FALSE ELEVATED ALINITY I TOXO IGG AND PROVIDED THE FOLLOWING DATA: CUSTOMER REFERENCE RANGE: POSITIVITY CUTOFF IS 1.2 IU/ML. SAMPLE ID (B)(6), INITIAL RESULT WAS 3.639 AND REPEAT RESULTS WERE 0.064 & 0.643. SAMPLE ID (B)(6), INITIAL RESULT WAS 10.516 AND REPEAT RESULTS WERE 0.062, 0.066 & 0.084. SAMPLE ID (B)(6), INITIAL RESULT WAS 2.053 AND REPEAT RESULTS WERE 0.079 & 0.127. PER THE CUSTOMER THE DISCREPANT RESULTS WERE NOT REPORTED OUT TO THE PATIENT¿S MEDICAL PROVIDER. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2614214 ALINITY I TOXO IGG REAGENT KIT ENZYME LINKED IMMUNOABSORBENT ASSAY, TOXOPLASMA GONDII LGD ABBOTT GMBH 66438BE00

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown ALNTY I PROCESSING MODU, 03R65-01, (B)(6)| ALNTY I PROCESSING MODU, 03R65-01, (B)(6)